Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Verapamil

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 92Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Societal CDMO Announces Signing of Amendment to License and Supply Agreement
    Societal CDMO Announces Signing of Amendment to License and Supply Agreement

    12 Jul 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/07/12/2477896/30326/en/Societal-CDMO-Announces-Signing-of-Amendment-to-License-and-Supply-Agreement-With-Lannett-for-Marketing-of-Verapamil-PM-and-Verelan-SR-Products.html

    GLOBENEWSWIRE
    12 Jul 2022
    Share Share
    Recro Pharma Announces 6y Extension of License Between Teva & Recro Gainesville
    Recro Pharma Announces 6y Extension of License Between Teva & Recro Gainesville

    16 Apr 2019

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2019/04/16/1804606/0/en/Recro-Pharma-Announces-Six-Year-Extension-of-License-and-Supply-Agreement-Between-Teva-and-Recro-Gainesville.html

    GLOBENEWSWIRE
    16 Apr 2019
    Share Share
    Mylan Pharmaceuticals Receives FDA Warning Letter
    Mylan Pharmaceuticals Receives FDA Warning Letter

    21 Nov 2018

    // FDA

    https://www.pharmacompass.com/pdf/news/mylan-pharmaceuticals-receives-fda-warning-letter-1542864425.pdf

    FDA
    21 Nov 2018
    Share Share
    DOJ's price-fixing investigation could lead to sizable liabilities, analyst says
    DOJ's price-fixing investigation could lead to sizable liabilities, analyst says

    10 Nov 2016

    // Eric Sagonowsky FIERCE PHARMA

    http://www.fiercepharma.com/pharma/doj-s-price-fixing-investigation-could-lead-to-sizable-liabilities-analyst-says

    Eric Sagonowsky FIERCE PHARMA
    10 Nov 2016
    Share Share
    Rusan Pharma Ltd fails EDQM Inspection
    Rusan Pharma Ltd fails EDQM Inspection

    04 Apr 2016

    // EDQM

    https://www.pharmacompass.com/pdf/news/rusan-pharma-ltd-fails-edqm-inspections-1459848264.pdf

    EDQM
    04 Apr 2016
    Share Share